HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--May 3, 2006--Immunicon Corporation (Nasdaq-NM:IMMC - News): Immunicon Corporation (Nasdaq-NM:IMMC - News), which is developing and commercializing proprietary cell- and molecular-based human diagnostic and life-science research products with an initial focus on cancer, today announced its operating results for the three months ended March 31, 2006.
